2 completed, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Streptococcus Pneumoniae Infection: new trials by email Literature Review of Streptococcus Pneumoniae Infection trials Research Report on Streptococcus Pneumoniae Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants 13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar 13 - Streptococcus Pneumoniae Infection | Phase 3 | Unknown | Fosun Adgenvax Biopharmaceutical Co.,Ltd. | 1800 | 2022-11-04 | 2024-10-01 |
| CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study PCV13 - Invasive Pneumococcal Disease, Protection Against, Streptococcus Pneumoniae Infection | Phase 2 / Phase 3 | Completed | University of British Columbia | 248 | 2018-08-23 | 2024-03-04 |
| Effect of Two Versus Three Pneumococcal Conjugate Vaccinations PCV7 - Streptococcus Pneumoniae Infection | Phase 3 | Completed | UMC Utrecht | 1005 | 2005-06-01 | 2011-08-22 |
Pneumococcal Infections (3) · Respiratory Tract Infections (1)
Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Streptococcal Infections (3) · Respiratory Tract Diseases (1)
13-valent pneumococcal vaccine (2) · Heptavalent Pneumococcal Conjugate Vaccine (1)
Fosun Adgenvax Biopharmaceutical Co.,Ltd. (1) · UMC Utrecht (1) · University of British Columbia (1)
Canada (1) · China (1)
Elisabeth A. M. Sanders, MD, PhD (1) · Manish Sadarangani, MD (1)
PMID 19584345, PMID 20823436, PMID 21695210, PMID 21813135, PMID 24120678, PMID 24447437, PMID 24921688, PMID 25329446